Prosecution Insights
Last updated: October 21, 2026

Hefei Nuomaiji Biotech Co. Ltd.

1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Hefei Nuomaiji Biotech Co. Ltd. has 1 pending office action currently under review. This matter is being handled by 1 distinct examiner, WECKER, JENNIFER, who accounts for the company's 1 pending office action. This indicates a highly localized point of contact within the patent office, where the outcome of the pending application rests entirely on the judgment and standards of this one examiner.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WECKER, JENNIFER 1 70.9% +36.6%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18701255 POCT MICROFLUIDIC CHIP AND DETECTION SYSTEM WECKER, JENNIFER —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18701255 POCT MICROFLUIDIC CHIP AND DETECTION SYSTEM WECKER, JENNIFER —

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18701255 POCT MICROFLUIDIC CHIP AND DETECTION SYSTEM WECKER, JENNIFER — §102§103 Non-Final OA — Pending Apr 15, 2024

Managing Hefei Nuomaiji Biotech Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Hefei Nuomaiji Biotech Co. Ltd. have?

Hefei Nuomaiji Biotech Co. Ltd. has 1 pending office actions as of October 2026, spread across 0 art units and 1 examiners.

Which USPTO examiner handles the most Hefei Nuomaiji Biotech Co. Ltd. applications?

Jennifer Wecker has the most, with 1 of Hefei Nuomaiji Biotech Co. Ltd.'s pending office actions.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month